News

Conférence ASPI / LES France 12 juin à paris

Patents

ASPI / LES France conference in Paris on 12th of june.

01 June, 2018

Cyra Nargolwalla will be speaking during the ASPI / LES France conference which will take place on Tuesday 12th of june in Paris.

The topic of her speech will be: Patentability of antibody on each side of the Atlantic: EPO’s jurisprudence and lessons from the case law Amgen c. Sanofi.

The conference will take place at the 54 Laffitte Club Confair, 54 Rue Laffitte à Paris.

Learn more about LES France here
Learn more about ASPI here

On the same expertise
By the same author

On the same expertise

Plasseraud IP at Adopt AI – Grand Palais International Summit 2025

20 November, 2025

Jérémie Palacci

Plasseraud IP at Adopt AI – Grand Palais International Summit 2025

On 25 and 26 November 2025, Jeremie Palacci, Partner at Plasseraud IP, will participate in the Adopt AI International Summit organised by Artefact at (...)

Plasseraud IP will take part in MEDICA

13 November, 2025

Atom Tong Xi Jun

The World Forum for Medicine held from November 17 to 20, 2025 in Düsseldorf, Germany. Our partner Atom TONG Xi Jun, European & Chinese Patent (...)

Allergen Alert, a deeptech company specializing in rapid food allergen detection for individuals and professionals, has raised €3.6 million in funding !

12 November, 2025

Denis Bourgarel

Allergen Alert, deeptech spécialisée dans la détection rapide des allergènes alimentaires à destination des particuliers et des professionnels, a annoncé une levée de fonds de 3,6 millions d’euros !

This investment will enable the company to finalize the technical development of its solution and accelerate the industrialization of its production (...)

Plasseraud IP is proud to sponsor the first ever trilateral seminar dedicated to young AIPPI members !

10 November, 2025

Jointly organized by the Young Members Committees of AIPPI France, Germany, and Italy, this unique event will take place on November 14, 2025, in (...)

$45 million Series A funding round for our client Genomines

6 November, 2025

Denis Bourgarel

$45 million Series A funding round for our client Genomines

Founded in 2021, Genomines is a deeptech startup that uses biotechnology to reinvent the mining industry. This funding will enable Genomines to (...)

Plasseraud IP welcomes Jérémie Palacci as Partner and strengthens its expertise in Artificial Intelligence and Quantum Computing

5 November, 2025

Jérémie Palacci

Press Release Paris, 4 November 2025 Plasseraud IP welcomes Jérémie Palacci as Partner and strengthens its expertise in Artificial Intelligence and (...)

Plasseraud IP at APAA 2025 in Kuala Lumpur

4 November, 2025

Guylène Kiesel Le Cosquer

Plasseraud IP à l’APAA 2025 à Kuala Lumpur

Our experts, Guylène Kiesel Le Cosquer, Partner and Board Member, and Ina Schreiber, Partner and Head of the Patent Department, represent Plasseraud (...)

Ipsen announces its intention to acquire ImCheck Therapeutics

4 November, 2025

Denis Bourgarel

Ipsen announces its intention to acquire ImCheck Therapeutics

On October 22, 2025, the biopharmaceutical group Ipsen announced that it had entered into a definitive agreement to acquire ImCheck Therapeutics, a (...)

Four Plasseraud IP experts ranked among the best in IAM Global Leaders 2026

29 October, 2025

Quatre experts de Plasseraud IP distingués parmi les meilleurs dans IAM Global Leaders 2026

Plasseraud IP is proud to announce that Cyra Nargolwalla, Bertrand Loisel, Eric Burbaud, and Ina Schreiber have once again been ranked among the best (...)

Plasseraud IP at the Osong Cosmetics & Beauty Expo 2025 in South Korea

27 October, 2025

Park Seowon

Plasseraud IP at the Osong Cosmetics & Beauty Expo 2025 in South Korea

On October 23, 2025, Vincent Girard and Seowon PARK, experts at Plasseraud IP, represented the firm at the conference organized by the FKCCI (French (...)

On the same expertise

Four Plasseraud IP experts ranked among the best in IAM Global Leaders 2026

5 November, 2025

Plasseraud IP is proud to announce that Cyra Nargolwalla, Bertrand Loisel, Eric Burbaud, and Ina Schreiber have once again been ranked among the best (...)

Cyra Nargolwalla and Nadine Rocaboy have been recognized in the IAM Strategy 300 and IAM Strategy 300 Global Leaders 2025 rankings

23 September, 2025

Cyra Nargolwalla

The IAM Strategy 300: The World’s Leading IP Strategists identifies professionals who stand out for their strategic vision and ability to maximize (...)

Plasseraud IP's patent department receives double recognition from IP Stars (Managing IP)

10 July, 2025

Le département brevet de Plasseraud IP doublement reconnu par IP Stars (Managing IP)

Plasseraud IP is delighted to once again be recognized as Tier 1 in the “Patent prosecution (2025)” category and, for the second time, as Tier 3 in (...)

Cyra Nargolwalla, Bertrand Loisel, Eric Burbaud, and Ina Schreiber recognized once again by IAM Global Leaders 2025

22 May, 2025

Cyra Nargolwalla, Bertrand Loisel, Eric Burbaud et Ina Schreiber reconnus une nouvelle fois par IAM Global Leaders 2025

Plasseraud IP is pleased to announce that Cyra Nargolwalla, Bertrand Loisel, Eric Burbaud and Ina Schreiber have once again been recognized among the (...)

Plasseraud IP Announces Major Governance Overhaul and New Leadership Appointments

5 May, 2025

Plasseraud IP annonce une refonte majeure de la gouvernance et la nomination d’une nouvelle direction

Paris, May 5, 2025 – Plasseraud IP, France’s leading IP firm, announces a major overhaul of its governance structure to support its continued growth (...)

Plasseraud IP ranked Tier 1 in The Legal 500 EMEA 2025, 3 experts individually ranked

27 March, 2025

Plasseraud IP classé Tier 1 dans The Legal 500 EMEA 2025, 3 experts dans le classement individuel

The 2025 edition of the Legal 500 EMEA guide, published on March 26, 2024, once again ranks Plasseraud IP as Tier 1 in the category dedicated to (...)

Cyra Nargolwalla, co-author of the ADAPT & IPO’s Practical Guide on Allyship, Mentorship, and Sponsorship

20 February, 2025

Cyra Nargolwalla

Are you looking for ways to foster diversity, equity, and inclusion within your organization? Do you want to understand the distinct roles of (...)

Plasseraud IP at the General Assembly and Conference on the Impact of AI on IP Rights of the AIPPI France

20 February, 2025

Cyra Nargolwalla

Plasseraud IP à l’Assemblée Générale et à la Conférence sur l'impact de l'IA sur les droits de PI de l’AIPPI France

Last week, Cyra Nargolwalla, Managing Partner, and Charlotte Leleu, Partner, had the pleasure of attending the General Assembly of the French Group (...)

Cyra Nargolwalla, Bertrand Loisel, Eric Burbaud and Ina Schreiber recognized as IAM Global Leaders 2025

31 October, 2024

Plasseraud IP is delighted to announce that Cyra Nargolwalla, Bertrand Loisel and Eric Burbaud, Managing Partners, have been recognized as leading (...)

SERI 2024, Recap of the Conference "Mentoring: An Accelerator for Success and Inclusion"

28 October, 2024

Cyra Nargolwalla

SERI 2024, Recap of the Conference "Mentoring: An Accelerator for Success and Inclusion"

How can French excellence become a vector for integration rather than a reproduction of inequalities? According to Les Echos START and Datagora (2022 (...)

On the same expertise

G 1/23 (“Solar Cell”) - New Standard for Prior Art

25 July, 2025

Lilia Leghmizi

On 27 June 2023, in case T 438/19, Technical Board 3.3.03 referred key questions to the Enlarged Board of Appeal about the conditions under which a (...)

T 1580/23 : the sole mention of a telecommunication standard in the description of a European patent is not sufficient to claim an effect relative to the implementation of the standard

17 July, 2025

Bruno Loubet

T 1580/23 : la seule mention d'une norme de télécommunication dans la description d'un brevet européen ne suffit pas à revendiquer un effet relatif à la mise en œuvre de la norme

The decision T 1580/23 of the Boards of Appeal 3.5.05 of the European Patent Office (EPO) is an appeal decision concerning an opposition against the (...)

G 1/24 : Claim Interpretation at the EPO - No Legal Anchor, but a Clear(er?) Path Forward

25 June, 2025

Nadine Rocaboy

G 1/24 Claim Interpretation at the EPO: No Legal Anchor, but a Clear(er?) Path Forward

The Enlarged Board of Appeal’s recent decision in G 1/24 has provided significant clarification regarding the interpretation of claims when assessing (...)

ChatGPT is not a skilled person

28 May, 2025

Louis Lavigne

In a recent decision T 1193/23 - 3.2.06 by the Boards of Appeal of the European Patent Office (EPO), the role of artificial intelligence, (...)

“Published after but filed before”: dealing with this kind of prior art - Obtaining an EP Patent - A crash course for the US applicant #8

6 February, 2025

Nadine Rocaboy

“Published after but filed before”: dealing with this kind of prior art - Obtaining an EP Patent - A crash course for the US applicant #8

“Published after but filed before”: dealing with this kind of prior art A patent application having a filing date earlier than the filing date of (...)

Landmark Decision by the Unified Patent Court: Shedding Light on Infringement by Equivalence

3 February, 2025

Nadine Rocaboy

Landmark Decision by the Unified Patent Court: Shedding Light on Infringement by Equivalence

By the end of 2024, the Unified Patent Court (UPC) offered a wonderful gift: the first decision ruling on infringement by equivalence. The decision (...)

Opposition in France: French specificities and initial assessment of oppositions for patents in class "A61" ("Medical or veterinary science; Hygiene").

4 July, 2024

Isabelle Magnin-Feysot

Opposition in France: French specificities and initial assessment of oppositions for patents in class "A61" ("Medical or veterinary science; Hygiene").

1/ General considerations on opposition proceedings in France Opposition proceedings for French patents before the French Patent Office (INPI), are (...)

EP and US patent offices expand their uses of e-signatures

5 April, 2024

Laurence Loumes

EP and US patent offices expand their uses of e-signatures

The EPO and the USPTO have issued recent decisions to expand the use of e-signatures, including the use of commercial solutions such as DocuSign® or (...)

Patent term: how to calculate the expiration date of an EP patent? - Obtaining an EP Patent - A crash course for the US applicant #7

4 April, 2024

Nadine Rocaboy

Obtaining an EP Patent - A crash course for the US applicant #7 - Patent term: how to calculate the expiration date of an EP patent?

Patent term: how to calculate the expiration date of an EP patent? In most patent legislations, the duration of a patent is generally 20 years from (...)

Claim fees: how to avoid their payment? - Obtaining an EP Patent - A crash course for the US applicant #6

5 March, 2024

Nadine Rocaboy

Obtaining an EP Patent - A crash course for the US applicant #6

Claim fees: how to avoid their payment? When filing a patent application, most patent legislations require the payment of claim fees above a certain (...)

*Périmètre